TRACKING INNOVATION: RUSSIA'S EVOLVING RESEARCH LANDSCAPE A CAS WHITEPAPER
|
|
- Oswald Johnston
- 5 years ago
- Views:
Transcription
1 TRACKING INNOVATION: RUSSIA'S EVOLVING RESEARCH LANDSCAPE A CAS WHITEPAPER
2 CAS analysis of the chemically-relevant research landscape in Russia illustrates a significant shift in focus in recent years. Historically, Russian scientific focus was scattered and evenly shared across many domains. Prior to 2010, patents from Russia heavily emphasized Unit Operations and Processes, patents that involved more theoretical research on chemicals and physical properties of materials. In the last 5 years, there has been tremendous growth in interest around pharmacology and pharmaceuticals, nearly doubling the share of the overall Russian scientific marketplace. One area that has remained strong is intellectual property development on manufacturing equipment. Figure 1: Shift in topics of patent applications from Russia. Source: CAS content collection. Last 5 years Last 20 years Analysis of the diseases being targeted by pharmacological research in Russia shows a primary interest in cancer and infections with a secondary emphasis on chronic disorders. The evolution of the most widely targeted disease in Russia over time is related to growth of the Russian economy. Initially, patents generated by Russian organizations focused on infectious diseases. In the last two years, cancer research has overtaken research on all other diseases. This pattern is a reflection of a shift toward age-related disorders and could be linked to higher life expectancy and overall health. Figure 2: Top 10 diseases targeted by patents over last 5 years. Source: CAS content collection. Figure 3: Shift in disease focus of patent applications Source: CAS content collection.
3 Patent publications in Russia have been driven primarily by organizations from the southern regions of Russia. Professors from Kuban State University, with its two schools of Technology and Agriculture, have generated over a third of all patents in the last 5 years. The chart below shows that patents are filed primarily by universities rather than privately owned companies. Figure 4: Leading organizations filing patents over the last 5 years. Source: CAS content collection. Despite the growth in interest around pharmaceuticals and pharmacology, established scientists in Russia are still heavily involved in industrial research. For example, plastics, ceramics and agrochemicals are still primary topics of interest to Russian scientists. The most prolific Russian institutions and organizations are universities based in the south, southeastern, and far east regions of the country. Figure 5: Top Russian organizations filing patents. Source: CAS content collection.
4 Unlike patent publications, research work published by Russian scientists in journals over the last 5 years remains in the theoretical areas of chemistry. The breakdown of academic studies by subject category shows the focus is on the chemical and physical properties of matter. As the foundation of material science and semiconductors, two critical applications of chemistry, Russia is well-positioned in these spaces. Yet, despite Russian industry shifting its focus towards pharmacology and pharmaceuticals, they are not widely studied in journal publications. There is opportunity for Russian academics to bridge the gap between industry and education by harnessing their knowledge base for pharmaceutical applications. Figure 6: Top research topics of journal articles published over the last 5 years. Source: CAS content collection. As expected, the majority of academic journal publications are published under the Russian Academy of Sciences, followed by world renowned Lomonosov Moscow State University. Beyond these institutions, the remaining universities have an approximately equal share of chemistry research published in scientific research journals. Figure 7: Top organizations publishing research in journals over the last 5 years. Source: CAS content collection.
5 Currently, Russian scientists publish their discoveries primarily within Russian scientific journals. In the last 5 years, journals from Russian academic institutes such as Bulletin of Experimental Biology and Medicine, Physics of the Solid State, Russian Chemical Bulletin, Russian Journal of Physical Chemistry (Zhurnal Fizicheskoi Khimli) and Russian Journal of General Chemistry are being published by the Springer Company. CAS solutions help make this research accessible to scientists around the world. With growing recognition of the impact of Russian research, there is greater opportunity for research from Russia to be published in journals established in other countries and journals in other languages. Figure 8: Top 10 journals based in Russia published in last 5 years. Source: CAS content collection. About CAS CAS, a division of the American Chemical Society, is dedicated to the ACS vision of improving people's lives through the transforming power of chemistry. Scientific researchers, patent professionals and business leaders around the world rely on our solutions that enable discovery and facilitate workflows to fuel tomorrow s innovation. With over 100 years experience, no one knows more about working with scientific information than CAS. Leverage our expertise to customize solutions for your organization s unique information challenges. Learn more at
Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight. Daria Iovcheva November, 2017
Illustration inspired by the work of John Maynard Keynes Springer Nature Nano/AdisInsight Daria Iovcheva November, 2017 1 Contents 1.0 About Springer Nature and our platforms 2.0 Nature Research Journals:
More informationFood and Agriculture
ABCD Food and Agriculture yet are quickly accessible from one central location. 7 Gain a competitive advantage 7 Facilitate product research and development 7 Raise return on investment Food and Agriculture:
More informationEd Turkel HPC Strategist
Dell EMC @ HPC on Wall St Ed Turkel HPC Strategist ed_turkel@dellteam.com Transforming the business Digital Transformation IT Transformation Workforce Transformation Security Transformation 2 Domain Experience
More informationFrom Bench To Clinic : a personal journey Career Research Advancement Focused Training
From Bench To Clinic : a personal journey Career Research Advancement Focused Training February 13, 2018 Irina Tcherepanova Ph.D. Vice President of Translational Medicine Argos Therapeutics Inc. FDA view
More informationSociety of Toxicology
Discover Kalamazoo Society of Toxicology Strategic Profile 2015-2018 Society of Toxicology Page 1 Society of Toxicology Strategic Profile: 2015 2018 PREAMBLE Life science is in the midst of rapid change
More informationE&T objectives in evolving pharma business models. Magda Chlebus Director Science Policy Brussels, 2 March 2015
E&T objectives in evolving pharma business models Magda Chlebus Director Science Policy Brussels, 2 March 2015 Education adapted to demand? Declining number of students choosing science Education still
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More informationWHITE PAPER. Artificial Intelligence, Human Expertise. How Technology and Trademark Experts Work Together to Meet Today s IP Challenges
WHITE PAPER Artificial Intelligence, Human Expertise How Technology and Trademark Experts Work Together to Meet Today s IP Challenges 2 Clarivate Analytics Artificial Intelligence, Human Expertise The
More informationUNLOCK YOUR POTENTIAL
Adding Value, Enhancing Skills UNLOCK YOUR POTENTIAL FOR EXCELLENCE IN BIOTECHNOLOGY Education Partner California, USA Adding Value, Enhancing Skills CENTER of EXCELLENCE for ADVANCED LEARNING in APPLIED
More informationPharmaceuticals and Biotechnology
ABCD Pharmaceuticals and yet are quickly accessible from one central location. 7 Gain a competitive advantage 7 Facilitate product research and development 7 Raise return on investment Pharmaceuticals
More informationThe overview of Estonian biotechnology sector (2012)
The overview of Estonian biotechnology sector (2012) Olavi Otepalu 15.06.2012, Tallinn Bioeconomy in the Baltics. Inspiration conference. Defining the biotechnology sector Always necessary prior to specify
More informationPhysician Leadership Academy Lead the future of health care
Lead the future of health care Module dates: Tuesday, October 16, 2018-Friday, October 19, 2018 Wednesday, January 9, 2019-Friday, January 11, 2019 Monday, March 25, 2019-Wednesday, March 27, 2019 Lead
More informationMONASH BIOMEDICINE DISCOVERY INSTITUTE. At a Glance. monash.edu/discovery-institute
MONASH BIOMEDICINE INSTITUTE At a Glance monash.edu/discovery-institute MONASH BIOMEDICINE INSTITUTE WHO WE ARE An institute with the scale and scope to tackle major research questions. We are one of the
More informationLEAP HR Life Sciences. Evolving Discovery Sciences at Merck. Jill Rapp Dietz, HR Leader
LEAP HR Life Sciences Evolving Discovery Sciences at Merck Jill Rapp Dietz, HR Leader 1 Agenda Merck Discovery Story.. What problem are we trying to solve for? Current Environment vs Future State Vision
More informationPIONEERING WORLD-CLASS DRUG DISCOVERY IN AFRICA
PIONEERING WORLD-CLASS DRUG DISCOVERY IN AFRICA MISSION & VISION Prof. Kelly Chibale H3D Director Vision To be the leading organisation for integrated drug discovery and development on the African continent.
More informationMASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery
MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY Faculty of Medicine and Surgery PRESENTATION This 2-Year Master s Degree in Biotechnology and Medical Biology bridges theoretical knowledge to hands-on
More informationTHE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE
THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE The promise of genomics to revolutionize medicine and to transform our understanding of life itself is one of the great opportunities of our time.
More informationDemocratized Data Driving Discovery RENCI Strategic Plan 2017
Democratized Data Driving Discovery RENCI Strategic Plan 2017 Stanley C. Ahalt, Ph.D. Director, Renaissance Computing Institute (RENCI) Professor, Department of Computer Science, UNC-Chapel Hill Associate
More informationInternational Pharmaceutical Federation (FIP) CEO
International Pharmaceutical Federation (FIP) CEO Profile of CEO with the International Pharmaceutical Federation (FIP), The Hague - the Netherlands Organization The International Pharmaceutical Federation
More informationBioWorld s PARTNER in FOCUS: Open Innovations: Moscow
BioWorld s PARTNER in FOCUS: Open Innovations: Moscow GLOBAL BIOPHARMA INDUSTRY SEES OPPORTUNITY IN RUSSIA Top executives from companies as diverse at Medtronic, Pfizer, EADS, Google, Sanofi Pasteur and
More informationDENMARK A COUNTRY OF QUALITY OVER QUANTITY. Innovation Attaché Lars Christensen, Innovation Centre Denmark
DENMARK A COUNTRY OF QUALITY OVER QUANTITY Innovation Attaché Lars Christensen, Innovation Centre Denmark BASIC R&D FACTS I Denmark is 200 times smaller than China in terms of geographical size and population.
More informationInaugural Fraunhofer Delaware Technology Summit
Inaugural Fraunhofer Delaware Technology Summit Energy and Life Sciences Solu
More informationEuropean Technology Platforms Conference Workshop on Education and Skills
European Technology Platforms Conference 2010 Workshop on Education and Skills Ferran Sanz Research Programme on Biomedical Informatics (GRIB) IMIM - Universitat Pompeu Fabra Barcelona Biomedical Research
More informationAbout the Healthcare Strategic Analysis Team Geographic specific reports: Global issue reports: 1. About This Report Chapter structure Executive
About the Healthcare Strategic Analysis Team Geographic specific reports: Global issue reports: 1. About This Report Chapter structure Executive summary Licensing trends overview Evolving trends in the
More informationSemantic Enrichment and the Information Manager
WHITEPAPER Semantic Enrichment and the Information Manager Turning Content into Insight It is more resource intensive to bring a drug to market than ever before: Pharmaceutical companies spend an average
More informationPresidential Commission for the Study of Bioethical Issues 2 nd meeting September
Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania
More informationPharmaceutical Industry in OIC Member Countries Production, Consumption and Trade
Pharmaceutical Industry in OIC Member Countries Production, Consumption and Trade STATISTICAL, ECONOMIC AND SOCIAL RESEARCH AND TRAINING CENTRE FOR ISLAMIC COUNTRIES O R G A N I Z A T I O N O F I S L A
More informationIndustry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development
Industry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development Aernout van Haarst PhD Director, European Corporate Development Feb 2016 Industry Academic Collaboration
More informationCancer Research UK; $500m annual research spend on basic research, drug discovery and clinical development
Cancer Research UK; $500m annual research spend on basic research, drug discovery and clinical development Phil L Huillier Director Cancer Research Technology Ltd London, UK Who we are Cancer Research
More informationM a x i m i z in g Value from NGS Analytics in t h e E n terprise
Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.idc-hi.com M a x i m i z in g Value from NGS Analytics in t h e E n terprise C U S T O M I N D U S T R Y B
More informationMedicine of the future: foresight
State Government Financed Institution of Higher Professional Education Siberian State MedicalUniversity Ministry of Health and Social Development of the Russian Federation Medicine of the future: foresight
More information395 South Youngs Road Buffalo, New York cognigencorp.com An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise
395 South Youngs Road Buffalo, New York 14221 716.633.3463 cognigencorp.com An On-Site 2-Day Workshop in Engineering The Pharmacometric Enterprise A Workshop For Improving the Efficiency and Effectiveness
More informationCI Information Hub. Incorporating Text Analysis into Business and Competitive Intelligence
CI Information Hub Incorporating Text Analysis into Business and Competitive Intelligence March 12, 2008 Iknow LLC 100 Overlook Center, 2nd Floor Princeton, New Jersey 08540-7814 T: (609) 419-0500 F: (609)
More informationSuccessful Academia-Pharma Collaboration Drug Discovery and Clinical Development
Successful Academia-Pharma Collaboration Drug Discovery and Clinical Development Toshio MIYATA Tohoku University Graduate School of Medicine United Centers for Advanced Research and Translational Medicine
More informationNortheastern Ontario Cancer Therapeutics Research Initiative (CTRI)
Northeastern Ontario Cancer Therapeutics Research Initiative (CTRI) Contents: 1. Project Summary 2. Operating Structure 3. Executive Summary 4. Financial supports requested 1. Project summary The land
More informationDENMARK A COUNTRY OF QUALITY OVER QUANTITY
DENMARK A COUNTRY OF QUALITY OVER QUANTITY PRESENTATION FOR TOUR OF CHINA INNOVATION ATTACHÉ LARS CHRISTENSEN, INNOVATION CENTRE DENMARK BASIC R&D FACTS Denmark is in a 7th place among OECD-countries in
More informationThe University of Alberta Faculty of Engineering
The University of Alberta Faculty of Engineering Engineers use creativity, scientific principles, and technological expertise to develop and advance the products and production methods that define the
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationDuncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline
R&D Strategy Bridging g the academia-industry industry yg gap Duncan Holmes European Head Discovery Partnerships with Academia GlaxoSmithKline GSK at a glance Who we are We are a science-led global healthcare
More informationThe HMO Research Network
The HMO Research Network Introducing the HMORN The HMO Research Network (HMORN) brings together research departments of some of the U.S. s best and most innovative health care systems. Collectively, the
More informationThe Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic
The Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic 1 The Irish Biomarker Network -Inaugural Workshop Improved Translation of Biomarkers to the Clinic Overview
More informationPioneering Clinical Omics
Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of
More informationConference Exhibitors
Conference Exhibitors CSM Executive and the 2018 Manitoba Local Organizing Committee would like to thank the following organizations for exhibiting and supporting the Canadian Society of Microbiologists
More informationThe Endocrine Society Strategic Plan 2011 (Approved by Council on June 2, 2011) Strategic Plan Overview
The Endocrine Society Strategic Plan 2011 (Approved by Council on June 2, 2011) Strategic Plan Overview Mission: The mission of The Endocrine Society is to advance excellence in endocrinology and promote
More informationDosing for Controlled Exposure (DoCE): Dosing strategies for characterising in vitro dose-responses with increased relevance for in vivo extrapolation
Dosing for Controlled Exposure (DoCE): Dosing strategies for characterising in vitro dose-responses with increased relevance for in vivo extrapolation Background Chemical safety assessments continue to
More informationNew Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation
New Ways to Source Innovation in the Healthcare Industry In-licensing needs Oncology of Janssen/Johnson & Johnson Innovation Dr. Klaus Suwelack Johnson & Johnson Innovation, Janssen-Cilag Germany, Neuss
More informationsocial, and population-based research conducted and supported by the National Institutes of Health (NIH). The
Statement by the Ad Hoc Group for Medical Research on FY 2015 Appropriations for the National Institutes of Health Submitted for the record on March 28, 2014, to the Subcommittee on Labor, Health and Human
More informationThe increase in overall life expectancy in the United States
THE FUTURE OF PHARMACEUTICAL CARE E. BLAKE WATKINS The increase in overall life expectancy in the United States and in other industrialized nations over the last 50 years is due, in part, to the explosion
More informationSYSTIMAX Solutions. imvision. Infrastructure Management. Made Easy.
SYSTIMAX Solutions imvision. Infrastructure Management. Made Easy. Every network must be managed. The question is HOW? The vision: Business success that starts with bettermanaged networks. Many organizations
More informationTHE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERS. ACCELERATING R&D and INNOVATION Keith MacGregor Executive Vice President November 12, 2010
THE HEALTHCARE & SCIENCE BUSINESS OF THOMSON REUTERS ACCELERATING R&D and INNOVATION Keith MacGregor Executive Vice President November 12, 2010 THOMSON REUTERS MARKETS DIVISION PROFESSIONAL DIVISION Sales
More informationConnecting biotechnology to product development in health, food and energy
Connecting biotechnology to product development in health, food and energy www.uncw.edu/crest With more than three decades of experience in marine and biotechnology research, UNCW has developed an international
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationCertification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union
Certification of qualified persons for pharmaceutical production conditions and requirements of the Eurasian Economic Union Natalya Pyatigorskaya Head of the Department of Industrial Pharmacy of the Sechenov
More informationBiological & Pharmaceutical Sciences July 12-13, 2019 Yokohama, Japan
conferenceseries.com 2 nd International Conference on Biological & Pharmaceutical Sciences July 12-13, 2019 Yokohama, Japan Theme: Evolution in Science is Inevitable - Exploring Pharma & Life Sciences
More informationPharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life
i3l PHARMACY BACHELOR PROGRAM The architect of drugs Improving the Quality of Life Pharmacy Message From the Head of Study Program Pharmaceutical products are essential to support various human health
More informationNANOSCIENCE AND NANOTECHNOLOGIES - Asia Nanoscience And Nanotechnology Development - Chunli Bai
ASIA NANOSCIENCE AND NANOTECHNOLOGY DEVELOPMENT Chunli Bai Chinese Academy of Sciences, China Keywords: Nano, Asia, Brief History, Administration and Implementation Sectors, Policies Characteristics Contents
More informationCareers in Novogene Europe Contact: Ms. Kelly Lu, HRBP Novogene Europe
Careers in Novogene Europe Contact: Ms. Kelly Lu, HRBP Novogene Europe Email: europe_hr@novogene.com Novogene Introduction: Novogene, headquartered in Beijing with branches in the U.S., U.K. and Singapore,
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationPost-Baccalaureate Program in Pharmaceutical Science. Accelerate your career
Post-Baccalaureate Program in Pharmaceutical Science Accelerate your career pharmsci.uci.edu pharmsci-grad@uci.edu 949.824.1991 Improve your career options The Post-Baccalaureate Program in Pharmaceutical
More informationApplication Note. NGS Analysis of B-Cell Receptors & Antibodies by AptaAnalyzer -BCR
Reduce to the Best Application Note NGS Analysis of B-Cell Receptors & Antibodies by AptaAnalyzer -BCR The software AptaAnalyzer harnesses next generation sequencing (NGS) data to monitor the immune response
More informationKonica Minolta to Acquire Invicro (US)
Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September
More informationProcedia - Social and Behavioral Sciences 156 ( 2014 ) Pavel Lebedev a *
Available online at www.sciencedirect.com ScienceDirect Procedia - Social and Behavioral Sciences 156 ( 2014 ) 580 584 19th International Scientific Conference; Economics and Management 2014, ICEM 2014,
More information6. Amsterdam Institute for Molecules, Medicine and Systems (AIMMS) VU University Amsterdam
6. Amsterdam Institute for Molecules, Medicine and Systems (AIMMS) VU University Amsterdam Assessments: Quality Relevance Viability AIMMS 1 2 1 6.1 Introduction and research area The Amsterdam Institute
More informationLife Sciences Debashis Ghosh. 1 Copyright 2016 Tata Consultancy Services Limited
Life Sciences Debashis Ghosh 1 Copyright 2016 Tata Consultancy Services Limited From biology, chemistry and anatomy to data, analytics and technology Analytics driven Genomics Research We identify disease
More informationIMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager
IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager Introducing IMI2: Vienna 16 July 2014 The way in which pharmaceutical companies develop new medicines
More informationCompetitive Strategies of Biotechnology Firms: Implications for U.S. Agriculture
Journal of Agricultural and Applied Economics, 29,1(July 1997):117-122 0 1997 Southern Agricultural Economics Association Competitive Strategies of Biotechnology Firms: Implications for U.S. Agriculture
More informationList of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.
Faculty 1 Adolescent Psychiatry Psychiatry 2 Anti Cancer Agents in Medicinal / Pharma & Quality 3 Anti-Infective Agents Pharmaceutical Microbiology 4 Anti-Inflammatory & Anti- Allergy Agents in Medicinal
More informationDefining the Expertise for the 21 st Century Neuroscience Workforce. James E. Barrett, Ph.D. Professor and Chair
Defining the Expertise for the 21 st Century Neuroscience Workforce James E. Barrett, Ph.D. Professor and Chair Department of Pharmacology and Physiology Drug Discovery and Development Program at Drexel
More informationThe Role of Philanthropy in Medical Device Development
The Role of Philanthropy in Medical Device Development The Federal Government, through the National Institutes of Health (NIH), often shoulders major funding for initial research in the life sciences.
More informationTURN INFORMATION INTO ACTIONABLE INSIGHTS
TURN INFORMATION INTO ACTIONABLE INSIGHTS VISIT WWW.TRYK360.COM TODAY TO SCHEDULE A LIVE DEMONSTRATION. A product of Cipher, the world s most trusted intelligence firm. IS INFORMATION OVERLOAD WEIGHING
More informationSchool of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15
School of Allied Medical Sciences Course Description Guide Associate in Medical Laboratory Sciences Page 1 of 15 Program Name & Definition: Associate in Medical Laboratory Sciences Laboratory sciences
More informationData Governance. Data Discovery.
Data Governance. Data Discovery. We work across teams to help organizations solve legal and regulatory challenges, starting at the source. Forensic Investigations FOR LEGAL TEAMS E-discovery Trial & deposition
More informationDrug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research
Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities
More informationTHE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE
THE HEALTHCARE SUPPLY CHAIN LEADER OF THE FUTURE BACKGROUND Organizations are finding it increasingly difficult to recruit and retain supply chain expertise and leadership, particularly as the delivery
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationIntegrated Value Management
Toray Group aims to be a corporate group that delivers exceptional value to each and every one of its stakeholders. Based on its corporate philosophy, contributing to society through the creation of new
More informationBD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President
BD Strategy Overview Advancing the world of health Vincent A. Forlenza Chairman, Chief Executive Officer and President BD IS AT THE VERY BEGINNING OF AN AMAZING JOURNEY WHERE WE CAN HAVE A PROFOUND IMPACT
More informationPARTNERING IN NEUROSCIENCE Sharing a Vision to Help Improve Patients Lives
PARTNERING IN NEUROSCIENCE Sharing a Vision to Help Improve Patients Lives VISIT OUR WEBSITE FOR MORE INFORMATION: www.janssen.com/neuroscience MAY 2017 Johnson & Johnson Innovation LLC 2017. A Message
More informationGE Healthcare. Financial Management Solutions
GE Healthcare Financial Management Solutions A transformational moment in healthcare The transition from volume-driven to value-driven healthcare is transforming how patient care is delivered and paid
More informationGenomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service
Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Professor Dame Sue Hill @CSOsue Chief Scientific Officer for England SRO Genomics, NHS England September 2018 Genomics:
More informationNIH-RAID: A ROADMAP Program
NIH-RAID: A ROADMAP Program (Rapid Access to Interventional Development} A Program designed to facilitate the development of new therapeutics The NIH-RAID Pilot Program is intended to reduce some of the
More informationTranslational Medicine From Discovery to Health
Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationLEADERSHIP STRATEGIES FOR AI + DIGITAL TRANSFORMATION
2 DAY PROGRAM (LIMITED AVAILABILITY) LEADERSHIP STRATEGIES FOR AI + DIGITAL TRANSFORMATION For leaders and key decisionmakers who drive the strategy and implementation of AI + digital transformation initiatives
More informationLecture 23: Clinical and Biomedical Applications of Proteomics; Proteomics Industry
Lecture 23: Clinical and Biomedical Applications of Proteomics; Proteomics Industry Clinical proteomics is the application of proteomic approach to the field of medicine. Proteome of an organism changes
More informationChemical Engineering
Programme Specification (Undergraduate) MEng Chemical Engineering This document provides a definitive record of the main features of the programme and the learning outcomes that a typical student may reasonably
More informationWelcome. Nottingham Trent University Challenges of Recruiting in a Global Marketplace. July
Welcome Nottingham Trent University Challenges of Recruiting in a Global Marketplace July 2008 Introduction Christina Kerr National Recruitment Marketing International Recruitment Overview PwC Global Resourcing
More informationCareer Growth Areas in Physiology / Pharmacology
Career Growth Areas in Physiology / Pharmacology Magdalena Alonso-Galicia, PhD Pharmacology Department Forest Research Institute, Inc. Jersey City, NJ 1 Career Growth Areas in BioPharma n Pharmaceutical
More informationStrategic Leadership and Innovation in High Technology Firms
University of Miami Scholarly Repository Management Faculty Articles and Papers Management 1-1-2009 Strategic Leadership and Innovation in High Technology Firms Terri A. Scandura PhD University of Miami,
More informationStands for purpose. Molecular Horizons: Centre for Molecular & Life Sciences
Stands for purpose Molecular Horizons: Centre for Molecular & Life Sciences MOLECULAR HORIZONS Understanding life, one molecule at a time The molecular life sciences are at the forefront of scientific
More informationTerritory Account Manager (MD, NC or TX based)
Territory Account Manager (MD, NC or TX based) Looking for bilingual Chinese-English young professionals with passion in selling genomics services. The Territory Account Manager's role is to ensure achievement
More informationFueling the Ship: Data Management in Focus. Derek Pratt Director, Citisoft
Fueling the Ship: Data Management in Focus Derek Pratt Director, Citisoft Data Is The New Oil Data is just like crude. It s valuable, but if unrefined it cannot really be used. It has to be changed into
More informationA Global CRO STRONGER TOGETHER
A Global CRO STRONGER TOGETHER About us Unique Service Offering the first agrochemical CRO to offer a truly global service Part of the Eurofins Scientific Group of companies, Eurofins Agroscience Services
More informationIsolation, purification, culturing and cryopreservation of primary cells from human samples
Research Technician Position description Position title: Research Technician Classification: HEW 5 Division/Department: Molecular Genetics of Cancer Work location: Parkville Position reference: WEHI/CADG
More informationPROUS SCIENCE INTEGRITY
PROUS SCIENCE INTEGRITY PROUS SCIENCE INTEGRITY + BIOMARKERcenter DECEMBER 2009 ENHANCEMENTS ENHANCEMENTS DECEMBER 2009 The December 2009 release of Prous Science Integrity and BIOMARKERcenter is designed
More informationDate/Lecturer Class Topic Readings 01/28/10 Brookman
Course Director: Sheldon, Ph.D. 01/28/10 1 I. Course Description and Requirements II. Historical Perspectives and Overview of Drug Development a. Evolution of the pharmaceutical industry b. Changing development
More informationKepler CORE. Phylogenetics. Astronomy. Library Science. Ecology. Conservation. Oceanography. Biology. Geosciences. Molecular. Biology.
Ecology Astronomy Phylogenetics Library Science COMET! Oceanography Geosciences Chemistry Kepler CORE Particle Physics Conservation Biology Molecular Biology ChIP-chip The Kepler-CORE Project and Team
More informationD.B.E. Digital Business Ecosystem. WP33: Dissemination and Community Building. D33.1: DBE Brand Identity Definition.
D.B.E. Digital Business Ecosystem Contract n 507953 WP33: Dissemination and Community Building D33.1: DBE Brand Identity Definition Project funded by the European Community under the Information Society
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationWAY TO SUCCESS FEMOFLOR
WAY TO SUCCESS 1993 Tercyc Multi-Channel PCR Thermal Cycler is the pioneer in DNA-Technology equipment product line. Until now, Tercyc is still unique in its class. More than 3 800 devices are in operation
More information